Alba Sanchez Viñas
Investigador pre-doc
Researcher Alba Sánchez has graduated in Pharmacy since 2016 from the University of Barcelona (UB). During the academic year 2014 - 2015 she did an Erasmus stay at Ege University (Turkey).
At the end of her undergraduate studies she started the master's degree in European Health Economics & Management (Eu-HEM), graduating in 2018 from the Erasmus Univeristy Rotterdam (Netherlands). During her master's studies she spent time at the University of Bologna (Italy) and at the Management Center Innsbruck (Austria).
In 2018, she was part of the team of quality advisors for biological medicines as internal research, within the Medicine Evaluation Board (MEB) of the Netherlands. She also has experience in community pharmacy and has held various roles in the pharmaceutical industry.
She is currently part of the PRISMA group as a predoctoral researcher in the line of adherence to antipsychotics.
Last Publications
- Peñarrubia-María MT, Maria Montserrat Gil Gribau, Maria del Carmen Gallardo González, Aznar-Lou, Ignacio, Serrano-Blanco A, Mendive Arbeloa JM, Garcia-Cardenas, Victoria, Sanchez-Vinas, Alba and Rubio-Valera M Non-initiation of prescribed medication from a Spanish health professionals' perspective: A qualitative exploration based on Grounded Theory. HEALTH & SOCIAL CARE IN THE COMMUNITY . 30(1): .
- Aznar-Lou I, Zabaleta-Del-Olmo E, Casajuana-Closas M, Sánchez-Viñas A, Parody-Rúa E, Bolíbar B, Iracheta-Todó M, Bulilete O, López-Jiménez T, Pombo-Ramos H, Martín Miguel MV, Magallón-Botaya R, Maderuelo-Fernández JÁ, Motrico E, Bellón J, Martí-Lluch R, Rubio-Valera M and Serrano-Blanco A Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study). INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY . 18(1): 88-88.
- Rubio-Valera M, Marqués-Ercilla S, Peñarrubia-María MT, Urbanos-Garrido RM, Borrell C, Bosch J, Sánchez-Viñas A and Aznar-Lou I Who Suffers From Pharmaceutical Poverty and What Are Their Needs? Evidence From a Spanish Region. FRONTIERS IN PHARMACOLOGY . 12: 617687-617687.